All centers are required to get your consent... it's the law I believe, or at least UNOS rules... dunno which.
If you get the call and they say "we have a kidney for you" your first response would not be "is it from an ECD" - but after reading this it might.
From the first time I was "on the list" in 1992 and again now in 2007 (no transplant, but different story for another time) it has always been my policy to ask these specific questions about a cadaveric donor, in this order of importance:1 - antigen match with me2 - cold time when I am called & location, (i.e. translants into travel time to get to my hospital)3 - cause of death4 - medical history5 - age
How about CMV positive or negative? Unless you're very specific, they may not volunteer the information, even if you ask for medical history.
And did they remove the transplanted kidneys after they failed?
What is CMV?
Quote from: kitkatz on February 10, 2007, 11:07:05 AMWhat is CMV?CMV is a common virus that they screen both donor and recipient for...they also screen for EBV. I'm not sure what CMV is short for,
Cytomegalovirus is the most common infectious complication in solid-organ transplant recipients. Despite the frequency of the problem, no commonly accepted approach to Cytomegalovirus prophylaxis and treatment exists. Because cytomegalovirus may lead to the modulation of the immune system sometimes causing opportunistic superinfections, allograft injury, acute rejection, chronic rejection, and development of posttransplant lymphoproliferative disease, transplant coordinators require knowledge of the disease, diagnostic methods, and treatment and prophylaxis strategies. This case study reviews a high-risk cytomegalovirus transplant recipient after living-related kidney transplantation. In addition to a review of the pathophysiology of the disease process, patient, family, and nursing staff education, and cultural and psychosocial aspects of cytomegalovirus, prophylaxis, diagnosis, treatment strategies as well as role of the transplant coordinator, will be discussed. (Progress in Transplantation. 2005;15:157-160)Cytomegalovirus (CMV) is a latent herpes virus that infects approximately 15% of adolescents and 50% of adults in the United States. The virus is transmitted through close physical contact, sexual intercourse, and blood transfusions.1 CMV rarely causes disease in the immunocompetent, but frequently reactivates in a compromised host, such as a solid-organ transplant recipient. When CMV primarily infects a previously uninfected recipient or a latent virus reactivates in the recipient, replication can occur in nearly any organ. In addition to the direct impact of the virus, CMV also leads to the modulation of the immune system, which can lead to opportunistic superinfections, allograft injury, acute rejection, chronic rejection, and development of posttransplant lymphoproliferative disease.CMV is the most common infectious complication in solid-organ transplant recipients. Despite the frequency of the problem, no commonly accepted approach to CMV prophylaxis and treatment exists.3 Patients who are CMV negative at the time of transplantation and receive a CMV-positive organ are considered to possess the highest risk of developing CMV disease (Table 1).5 The following case review will outline a young woman's clinical course of CMV after kidney transplantation. The role of the transplant coordinator, cultural aspects of the patient care, and the psychosocial issues surrounding CMV after transplantation will be discussed.
Quote from: kitkatz on February 10, 2007, 11:07:05 AMWhat is CMV?Just wanted to add, if both recipient and donor are negative for anti-CMV Igm antibodies, the incidence of CMV is <5%. If recipient is CMV+, the incidence of infection (independent of the donor status) is about 25%-40%. Clinical infection occurs 3-4 mos. post txp. during maximal immunosuppression.It should be noted that many deceased donors receive many blood transfusions, and it should be presumed that 1 or more units carry the virus. In most cases, recipients receive valcyte at least the first 3 months after surgery. Its an expensive drug, and when I had my txp. was told that it was not covered by medicare. That was one of the things discussed pre-transplant (to make sure I could afford it). Also, Angie is right, there is no cure, but there have been some successes of preventing CMV disease vs CMV infection post transplant with the use of gancyclovir and valacyclovir. There is a difference between CMV infection (where detection of the CMV antibody is present) and CMV disease (which presents clinically as fever, hi white count, hepatitis, pneumonia, things that can lead to organ rejection).
I still have my moms kidney in me... and i didnt have to take prednisone the rest of my life. Actually im not on prednisone this translant, which is great.
Well shit! Another damned thing to worry about!Sorry about the curse words, but geez!
Scripps hospital told us that nearly all of the adult population has been exposed to CMV, and that it canlie dormant, undetected, until immunosuppressants are on board. So they routinely treat every transplant patient with Valcyte.